We have located links that may give you full text access.
Design, synthesis, and biological evaluation of itaconic acid derivatives as potential anti-influenza agents.
Journal of Medicinal Chemistry 2019 Februrary 13
Influenza A viruses (IAVs) have caused worldwide epidemics and pandemics by reassortment and generation of drug-resistant mutants, which renders antivirals and current vaccinations no longer usable. In this study, an itaconic acid derivative 1 was identified from a chemical library of 20,000 compounds by performing a cell-based screening assay as a lead agent exhibiting anti-influenza A activity. Accordingly, a series of itaconic acid derivatives were designed and synthesized by adopting a rational design strategy to obtain more potent anti-influenza agents. The results of an in vitro pharmacological study showed that compounds 4 and 8 exhibited the most potent anti-IAV effect with EC50 values of 0.14 and 0.11 µM, respectively, in Madin-Darby canine kidney cells. Mechanisms of action studies showed that lead agents 1 and 4 reduced virus replication by directly targeting IAV nucleoproteins and disrupting virus ribonucleoprotein export from nucleus to cytosol. On the basis of its high potential as an anti-IAV agent and its selectivity index > 785, compound 4 was found to be a promising candidate for further development against IAVs.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app